期刊文献+

miR-214介导慢性淋巴细胞白血病对氟达拉滨耐药的作用研究 被引量:4

Effect of miR-214 on Fludarabine Resistance in Chronic Lymphocytic Leukemia
下载PDF
导出
摘要 目的:探讨miR-214在慢性淋巴细胞白血病(CLL)细胞对氟达拉滨耐药中的作用及机制。方法:选择2014年08月-2018年07月P本院血液科收治对氟达拉滨(Flu)耐药的CLL患者和健康受试者各10例,采用RTPCR法测定单个核细胞中miR-214表达水平。将CLL患者原代细胞分为空白对照组(control group)、阴性对照组(miR-214-NC group)和miR-214转染组(miR-214-ASO group)。转染病毒24 h后与Flu共同培养48 h,测定细胞增殖和凋亡情况,以及PTEN和PI3K/AKT信号通路下游相关基因和蛋白表达水平。结果:CLL患者单个核细胞miR-214的表达水平较健康受试者显著升高(P<0.05);miR-214转染组细胞miR-214表达水平显著降低(P<0.05);miR-214转染组细胞在Flu浓度为3、10和30μmol/L时的吸光度显著降低(P<0.05);Flu浓度为10 mmol/L时miR-214转染组细胞的凋亡率显著增高(P<0.05),PTEN和BAD m RNA水平显著增高(P<0.05),MDM2和NF-κB m RNA水平显著降低(P<0.05),PTEN和p-BAD蛋白水平显著增高(P<0.05),MDM2和NF-κB蛋白水平显著降低(P<0.05)。结论:抑制miR-214可以提高耐药的CLL细胞对氟达拉滨的敏感性,这种作用可能与其促进细胞凋亡有关,并且与其调节PTEN/AKT信号通路下游分子表达有关。 Objective:To investigate effect and mechanism of miR-214 in fludarabine resistance of chronic lymphocytic leukemia(CLL).Methods:A total of 10 patients with CLL resistante to fludarabine(Flu)and 10 healthy persons admitted to Hematology Department of our hospital in August 2014-July 2018 were selected.Expression level of miR-214 in mononuclear cells in patients with CLL and healthy persons were determined by RT-PCR.Primary CLL cells from patients with CLL were divided into normal control group(control group),negative control group(miR-214-NC group)and viral transinfection group(miR-214-ASO group).After 24 h-transfection,CLL cells were cultured with different con-centration of Flu for 48 h,then the cell proliferation and apoptosis were detected,and the levels of down-stream genes and proteins releted with PTEN and PI3 K/AKT signialing pathway were determined.Results:The expression level of miR-214 in mononuclear cells of CLL patients significantly increased in comparison with healthy persons(P<0.05);the expression level of miR-214 in miR-214-ASO group significantly decreased(P<0.05);Absorbance in control group at Flu concentration of 3,10 and 30μmol/L was significantly decreased(P<0.05).Apoptosis rate in miR-214-ASO group at Flu concentration of 10 mmol/L significantly increased(P<0.05).At Flu concentration of 10 mmol/L,mRNA levels PTEN and BAD in miR-214-ASO group significantly increased(P<0.05),but mRNA levels of MDM2 and NF-κB significantly decreased(P<0.05).At Flu concentration of 10 mmol/L,protein levels of PTEN and p-BAD in miR-214-ASO group significantly increased(P<0.05),but protein levels of MDM2 and NF-κB significantly decreased(P<0.05).Conclusion:Inhibition of miR-214 can enhance the sensitivity of drug-resistant CLL cells to fludarabine,which may be raleted with the promotion of cell apotosis and regulation of down-stream molecules expression of PTEN/AKT signaling pathway.
作者 邹志建 孙鸿丽 沈云峰 周新 ZOU Zhi-Jian;SUN Hong-Li;SHEN Yun-Feng;ZHOU Xin(Department of Hematology,The Affiliated Wuxi People's Hospital of Nanjing Medical University,Wuxi 214023,Jiangsu Province,China)
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2019年第5期1395-1401,共7页 Journal of Experimental Hematology
基金 南京医科大学科技发展基金重点项目(2015NJMUZD067)
关键词 慢性淋巴细胞白血病 miR-214 氟达拉滨 耐药 PTEN/AKT信号通路 chronic lymphocytic leukemia miR-214 Fludarabine drug resistance PTEN/AKT signaling pathway
  • 相关文献

参考文献7

二级参考文献49

  • 1王雨,刘春英.补中益气汤对A549荷瘤小鼠脾脏上Caspase-3蛋白表达影响研究[J].中国生化药物杂志,2014,34(1):19-21. 被引量:7
  • 2李丽,徐卫,李建勇.慢性淋巴细胞白血病预后因素研究进展[J].中华内科杂志,2006,45(9):781-783. 被引量:17
  • 3柳萌,杨迪生.顺铂耐药机制的研究进展[J].现代中西医结合杂志,2007,16(6):856-858. 被引量:10
  • 4Xu W, Li JY, Wu YJ, et al. CD38 as a prognostic factor in Chinese patients with chronic }ymphocytie leukaemia. Leuk Res, 2009; 33 (2) :237 -243.
  • 5Chen L, Zhang Y, Zheng W, et al. Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia. Leuk Res, 2008, 32 (10) : 1491 - 1498.
  • 6Shi JY, Shi ZZ, Zhang SJ, et al. Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients. Pharmacogenetics, 2004; 14(11) :759 -768.
  • 7Cejkova S, Rocnova L, Potesil D, et al. Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine. Eur J Haematol, 2009; 82(2) :133 - 142.
  • 8Kojima K, Konopleva M, McQueen T, et al. Mdm2 inhibitor Nutlin- 3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Arm-media- ted resistance to fludarabine in chronic lymphocytic leukemia. Blood, 2006; 108(3) :993 - 1000.
  • 9Roberts JD, Smith MR, Feldman E J, et al. Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma. Clin Cancer Res, 2006 ; 12(19) :5809 -5816.
  • 10Mangelsdorf D J, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade[J]. Cell, 1995, 83(6): 835-9.

共引文献94

同被引文献26

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部